Performance of Oral Rotavirus Vaccines in Low- and Middle-Income Settings: Current Evidence, Persistent Gaps and Future Directions
Viruses · 21.08.2026 · 18 (8) · 917
DOI: 10.3390/v18080917 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 21.08.2026. Verfasst von Bharathikumar Sivakumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College, Vellore 632004, India. Hauptthemen laut MEDLINE: Rotavirus Vaccines, Rotavirus Infections. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Oral, live-attenuated rotavirus vaccines (ORVs) have significantly reduced severe diarrheal disease and deaths; however, vaccine performance in low- and middle-income countries (LMICs) remains lower than in high-income countries. With increasing global use, real-world data now provide important insights into strategies to improve vaccine impact in these settings. This review summarizes current evidence on the effectiveness and impact of ORVs in LMICs, with a focus on approaches to optimize performance, including alternative dosing schedules, booster doses in late infancy, and mixed vaccine regimens. Evidence on vaccine interchangeability offers practical solutions for countries facing supply disruptions and financial constraints. The review also highlights the growing importance of economic sustainability, particularly in the context of transitions from external funding support. Despite lower efficacy, ORVs continue to provide substantial public health benefits in LMICs. Sustained impact will depend on strengthening programme delivery, ensuring stable vaccine supply, and advancing next-generation vaccines. Continued evaluation of effectiveness, cost, and implementation strategies will be critical to maximizing long-term benefits in high-burden settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College, Vellore 632004, India.
- WHO Regional Office for Africa (WHO/AFRO), Brazzaville P.O. Box 06, Congo.
- Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
- Center for Public Health, Christian Medical College, Vellore 632004, India.
ORCID-Profile: Bharathikumar Sivakumar, Jason Mathiu Mwenda, Tintu Varghese
Zitieren
APA
Sivakumar, B., Mwenda, J. M., Lopman, B. A., Kang, G., & Varghese, T. (2026). Performance of Oral Rotavirus Vaccines in Low- and Middle-Income Settings: Current Evidence, Persistent Gaps and Future Directions. Viruses, 18(8), 917. https://doi.org/10.3390/v18080917
Vancouver
Sivakumar B, Mwenda JM, Lopman BA, Kang G, Varghese T. Performance of Oral Rotavirus Vaccines in Low- and Middle-Income Settings: Current Evidence, Persistent Gaps and Future Directions. Viruses. 2026;18(8):917. doi:10.3390/v18080917
BibTeX
@article{Sivakumar2026,
author = {Sivakumar, Bharathikumar and Mwenda, Jason Mathiu and Lopman, Benjamin Alan and Kang, Gagandeep and Varghese, Tintu},
title = {Performance of Oral Rotavirus Vaccines in Low- and Middle-Income Settings: Current Evidence, Persistent Gaps and Future Directions},
journal = {Viruses},
year = {2026},
volume = {18},
number = {8},
pages = {917},
doi = {10.3390/v18080917}
}
EUVIMED